[Acute respiratory distress syndrome: incidence and course in a Spanish ICU]

Autor: Jr, Masclans Enviz, Mj, Burgueño Campiñez, Bermejo Fralle B, Anglès Coll R, Ricard Ferrer, Fj, Latorre Arteche

Publikováno v: Europe PubMed Central

We have analyzed the 57 ARDS admitted at the Intensive Care Unit (ICU) of the Hospital General Vall d'Hebron of Barcelona in 1996 (the 5.7% of the ICU and the 0.18% of the hospital admission). We have studied the epidemiological characteristics, as w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9523a7faf69effe0cd194f6c852e11b0
https://pubmed.ncbi.nlm.nih.gov/9658908

Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity.

Autor: Luque S; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical, Pharmacology, University of Liverpool and Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom sluque@parcdesalutmar.cat.; Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical, Pharmacology, University of Liverpool and Royal Liverpool Broadgreen University Hospital Trust, Liverpool, United Kingdom., Sorli L; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, España.; Infectious Diseases Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Muñoz-Bermudez R; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.; Critical Care Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Critical Illness Research Group (GREPAC), Institut Mar d'Investigaciones Mèdiques, Barcelona, Spain., Campillo N; Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain., Barceló-Vidal J; Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain., Álvarez-Lerma F; Critical Care Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Critical Illness Research Group (GREPAC), Institut Mar d'Investigaciones Mèdiques, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Horcajada JP; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, España.; Infectious Diseases Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Masclans-Enviz JR; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.; Critical Care Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Critical Illness Research Group (GREPAC), Institut Mar d'Investigaciones Mèdiques, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Neely M; Children's Hospital Los Angeles, University of Southern California. Los Angeles, California, USA., Grau S; Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.; Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, España.; Universitat Autònoma de Barcelona, Barcelona, Spain.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 May 18; Vol. 65 (6). Date of Electronic Publication: 2021 May 18 (Print Publication: 2021).